127 related articles for article (PubMed ID: 7589037)
1. Classification of drugs for teratogenic risk.
Alván G; Danielsson BR; Kihlström I; Lundborg P; Prame B; Ridley E; Sannerstedt R
Eur J Clin Pharmacol; 1995; 48(3-4):177-8. PubMed ID: 7589037
[No Abstract] [Full Text] [Related]
2. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
3. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.
Friedman JM
Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499
[No Abstract] [Full Text] [Related]
4. Classification of drugs for teratogenic risk: an anachronistic way of counseling.
Merlob P; Stahl B
Teratology; 2002 Aug; 66(2):61-2. PubMed ID: 12210007
[No Abstract] [Full Text] [Related]
5. Classification of drugs for teratogenic risk: an anachronistic way of counseling: a reply to Merlob And Stahl.
Briggs GG; Freeman RK; Yaffe SJ
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):207-8. PubMed ID: 12797465
[No Abstract] [Full Text] [Related]
6. FDA's classification of new drugs.
Schneiweiss F
N Engl J Med; 1980 Jun; 302(24):1368-9. PubMed ID: 7374693
[No Abstract] [Full Text] [Related]
7. The FDA's classification system for new drugs. An evaluation of therapeutic gain.
Finkel MJ
N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458
[No Abstract] [Full Text] [Related]
8. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
[TBL] [Abstract][Full Text] [Related]
9. Classification of new drug clinical evaluations.
Hodges RM
J Clin Pharmacol J New Drugs; 1968; 8(5):277-8. PubMed ID: 4877182
[No Abstract] [Full Text] [Related]
10. Human teratogens: update 2010.
Holmes LB
Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
[TBL] [Abstract][Full Text] [Related]
11. Are drugs within a class interchangeable?
Furberg CD; Herrington DM; Psaty BM
Lancet; 1999 Oct; 354(9185):1202-4. PubMed ID: 10513728
[No Abstract] [Full Text] [Related]
12. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
Uhl K; Kennedy DL; Kweder SL
Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
[TBL] [Abstract][Full Text] [Related]
13. Evolving knowledge of the teratogenicity of medications in human pregnancy.
Adam MP; Polifka JE; Friedman JM
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
[TBL] [Abstract][Full Text] [Related]
14. FDA new drug approvals in 2009.
Wynn RL
Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770
[No Abstract] [Full Text] [Related]
15. Old, new, and not new drugs.
Knobloch CP
J Am Vet Med Assoc; 1979 Oct; 175(7):698. PubMed ID: 528312
[No Abstract] [Full Text] [Related]
16. Technology. Tracking drugs.
Haugh R
Hosp Health Netw; 2006 Apr; 80(4):22. PubMed ID: 16703824
[No Abstract] [Full Text] [Related]
17. The FDA's new drug rating system.
Ohio Med; 1991 Mar; 87(3):133-4. PubMed ID: 2030884
[No Abstract] [Full Text] [Related]
18. Plan BTC: the case for a third class of drugs in the United States.
Healey D
Food Drug Law J; 2008; 63(1):375-89. PubMed ID: 18561465
[No Abstract] [Full Text] [Related]
19. The clinical value of FDA class C drugs approved from 1981 to 1988.
Yasuda SU; Woosley RL
Clin Pharmacol Ther; 1992 Dec; 52(6):577-82. PubMed ID: 1458766
[No Abstract] [Full Text] [Related]
20. Pregnancy and pills.
Rochman B
Time; 2009 Jun; 173(22):51-3. PubMed ID: 19522199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
